FindTrial
Sign In

To construct a prediction model for pathological progression of esophageal low-grade squamous neoplasia after endoscopic treatment

To construct a prediction model for pathological progression of esophageal low-grade squamous neoplasia after endoscopic treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053147
Enrollment
Unknown
Registered
2021-11-13
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal squamous low-grade intraepithelial neoplasm

Interventions

Case group:None
Not upgraded group:None

Sponsors

Jiangsu Province Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.All patients who underwent endoscopic submucosal dissection with biopsy pathology indicating low-grade intraepithelial neoplasia of esophageal squamous epithelium during 2015-2021; 2.Complete pathological results of preoperative biopsy and complete resection of pathological specimens after endoscopic treatment; 3.Complete preoperative white light endoscopy, pigment magnifying endoscopy and ultrasonic endoscopy were performed.

Exclusion criteria

Exclusion criteria: 1.All esophageal non-squamous intraepithelial neoplasia (including Barrett's esophagus, etc.); 2.Patients who have a history of other gastrointestinal tumors or surgery, or who have received anti-tumor therapy; 3.Patients aged< 18 years.

Design outcomes

Primary

MeasureTime frame
Rate of pathological progression after endoscopic treatment;—

Countries

China

Contacts

Public ContactZhang Guoxin

Jiangsu Province Hospital

guoxinz@njmu.edu.cn+86 13951913128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026